866-997-4948(US-Canada Toll Free)

Cancer diagnostics tests are primarily used to identify cancer at an early stage when it is mostly treatable. It helps to predict prognosis and direct treatment, keep a tab on the treatment, and disease progression or recurrence. Cancer diagnostics has witnessed a sea change on account of the rapid technological progress resulting in cutting-edge platforms. Emergence of hybrid imaging instruments such as PET/CT and SPECT/CT has dramatically upped accuracy of tests. Such developments has majorly boosted the market for cancer diagnostics.

Lack of skilled professionals to conduct such diagnostics tests, however, has crimped their demand to some extent.

Cancer diagnostics technology can be broadly divided into platform-based and instrument-based. They can be used to uncover lung cancer, breast cancer, colorectal cancer, melanoma, and others.

Cancer diagnostics tests sees maximum demand from North America, where the incidence of cancer is higher than anywhere else. North America is trailed by Europe and Asia.